Mosaic ImmunoEngineering (CPMV) Retained Earnings (2011 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Retained Earnings of $2.1 million for Q1 2026, little changed year-over-year from $2.1 million in Q1 2025, and little changed quarter-over-quarter from $2.1 million in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Retained Earnings (2011 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Retained Earnings history runs 16 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Retained Earnings changed 0.0% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (changed 0.0% YoY), while the FY2025 annual figure was $2.1 million, up 123.2% from the prior year.
- Retained Earnings for Q1 2026 stood at $2.1 million, roughly flat from $2.1 million in the prior quarter.
- The five-year high for Retained Earnings was $2.1 million in Q1 2025, with the low at -$9.4 million in Q3 2025.
- The 5-year median for Retained Earnings is -$5.3 million (2022), against an average of -$3.2 million.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings soared 138.34% in 2023, then slumped 532.15% in 2024.
- Mosaic ImmunoEngineering's Retained Earnings stood at $2.0 million in 2022, then gained by 1.08% to $2.0 million in 2023, then plunged by 532.15% to -$8.8 million in 2024, then soared by 123.2% to $2.1 million in 2025, then changed by 0.0% to $2.1 million in 2026.
- Business Quant data shows CPMV's Retained Earnings at $2.1 million in Q1 2026, $2.1 million in Q4 2025, and -$9.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -6.33 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.57 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 4.38 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 20.91 Bn |
| 10 | Mosaic ImmunoEngineering | 527,536.97 | 527,536.97 | - | -9.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.05 Mn |
| Dec 31, 2025 | 2.05 Mn |
| Sep 30, 2025 | -9.36 Mn |
| Jun 30, 2025 | -9.19 Mn |
| Mar 31, 2025 | 2.05 Mn |
| Dec 31, 2024 | -8.84 Mn |
| Sep 30, 2024 | -8.69 Mn |
| Jun 30, 2024 | -8.50 Mn |
| Mar 31, 2024 | -8.20 Mn |
| Dec 31, 2023 | 2.05 Mn |
| Sep 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 2.02 Mn |
| Sep 30, 2022 | -6.37 Mn |
| Jun 30, 2022 | -6.22 Mn |
| Mar 31, 2022 | -5.29 Mn |
| Dec 31, 2021 | 1.73 Mn |
| Sep 30, 2021 | -3.68 Mn |
| Jun 30, 2021 | -2.63 Mn |